Skip to main content
SpringerLink
Log in

Organerhaltende Therapie beim Peniskarzinom

Organ-preserving therapy for penile carcinoma

  • Leitthema
  • Published:
Der Urologe Aims and scope Submit manuscript

Zusammenfassung

In den letzten Jahren hat sich ein deutlicher Wandel hin zur organerhaltenden, rekonstruktiven Therapie des Peniskarzinoms ergeben. Die operative Therapie strebt heute unter Wahrung schnittfreier Tumorränder bei risikoadaptiert bemessenen, deutlich geringeren Sicherheitsabständen zum Tumor einen weitgehenden Erhalt der penilen Strukturen oder deren plastische Rekonstruktion an, um einen funktionell und kosmetisch akzeptablen Zustand zu erreichen. Die onkologische Sicherheit bezogen auf das Langzeitüberleben wird dadurch nicht beeinträchtigt, eine höhere Lokalrezidivrate muss allerdings in Kauf genommen werden.

Abstract

In recent years, a definite change towards organ-sparing, reconstructive local treatment of penile cancer has been observed. Surgical treatment aims to achieve margin-free resections with risk-adapted much smaller safety margins. Thus, the penile structures are preserved as far as possible or reconstructed in order to achieve a functionally and cosmetically satisfactory result. The oncological safety concerning tumor-free survival is not compromised. However, a higher rate of local recurrences has to be accepted.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Abb. 1
Abb. 2
Abb. 3
Abb. 4
Abb. 5

Literatur

  1. Arya M, Li R, Pegler K et al (2013) Long-term trends in incidence, survival and mortality of primary penile cancer in England. Cancer Causes Control 24(12):2169–2176

    Article  PubMed  Google Scholar 

  2. Lont AP, Kroon BK, Horenblas S et al (2006) Presence of high risk human papilllomavirus DNA in penile carcinoma predicts favorable outcome in survival. Int J Cancer 119(5):1078–1081

    Article  CAS  PubMed  Google Scholar 

  3. Stankiewicz E, Kudahetti SC, Prowse DM et al (2009) HPV infection and immunochemical detection of cell-cycle markers in verrucous carcinoma of the penis. Mod Pathol 22:1160–1168

    Article  CAS  PubMed  Google Scholar 

  4. Chaux A, Netto GJ, Rodríguez IM et al (2013) Epidemiologic profile, sexual history, pathologic features, and human papillomavirus status of 103 patients with penile carcinoma. World J Urol 31(4):861–867

    Article  PubMed Central  PubMed  Google Scholar 

  5. Backes DM, Kurman RJ, Pimenta JM et al (2009) Systematic review of human papillomavirus prevalence in invasive penile cancer. Cancer Causes Control 20(4):449–457

    Article  PubMed  Google Scholar 

  6. Alnajjar HM, Lam W, Bolgeri M et al (2012) Treatment of carcinoma in situ of the glans penis with topical chemotherapy agents. Eur Urol 62(5):923–928

    Article  CAS  PubMed  Google Scholar 

  7. Crook J, Grimard L, Pond G et al (2007) Penile brachytherapy: results for 60 patients. Urology 70(3):161–164

    Article  Google Scholar 

  8. Albers P (Hrsg) (2007) Penistumoren, 3.überarbeitete Aufl. Thieme, Stuttgart

  9. Heidenreich A, Pfister D (Hrsg) (2010) Peniskarzinom. Springer, Berlin Heidelberg New York

  10. Ornellas AA, Kinchin EW, Nóbrega BL et al (2008) Surgical treatment of invasive squamous cell carcinoma of the penis: Brazilian National Cancer Institute long-term experience. J Surg Oncol 97(6):487–495

    Article  PubMed  Google Scholar 

  11. Protzel C, Alcatraz A, Horenblas S et al (2009) Lymphadenectomy in the surgical management of penile cancer. Eur Urol 55(5):1075–1088

    Article  PubMed  Google Scholar 

  12. Leijte JA, Kirrander P, Antonini N et al (2008) Recurrence patterns of squamous cell carcinoma of the penis: recommendations for follow-up based on a two-centre analysis of 700 patients. Eur Urol 54(1):161–168

    Article  PubMed  Google Scholar 

  13. Djajadiningrat RS, Werkhoven E van, Meinhardt W et al (2014) Penile sparing surgery in penile cancer: does it affect survival? J Urol 191(1):68–73

    Article  PubMed  Google Scholar 

  14. Minhas S, Kayes O, Hegarty P et al (2005) What surgical resection margins are required to achieve oncological control in men with primary penile cancer? BJU Int 96(7):1040–1043

    Article  PubMed  Google Scholar 

  15. Hakenberg OW, Comperat E, Minhas S et al (2014) Guideline on penile cancer. Eur Urol (im Druck)

  16. Gunia S, Burger M, Hakenberg OW et al (2013) Inherent grading characteristics of individual pathologists contribute to clinically and prognostically relevant interobserver discordance concerning Broders‘ grading of penile squamous cell carcinomas. Urol Int 90(2):207–213

    Article  PubMed  Google Scholar 

  17. Kakies C, Lopez-Beltran A, Comperat E et al (2014) Reproducibility of histopathologic tumor grading in penile cancer-results of a European project. Virchows Arch 464(4):453–461

    Article  PubMed  Google Scholar 

  18. Shabbir M, Muneer A, Kalsi J et al (2011) Glans resurfacing for the treatment of carcinoma in situ of the penis: surgical technique and outcomes. Eur Urol 59(1):142–147

    Article  PubMed  Google Scholar 

  19. Morelli G, Pagni R, Mariani C et al (2009) Glansectomy with split-thickness skin graft for the treatment of penile cancer. Int J Impot Res 21(5):311–314

    Article  CAS  PubMed  Google Scholar 

  20. Gerullis H, Georgas E, Bagner JW et al (2013) Construction of a penoid after penectomy using a transpositioned testicle. Urol Int 90(2):240–242

    Article  CAS  PubMed  Google Scholar 

  21. Zukiwskyj M, Daly P, Chung E (2013) Penile cancer and phallus preservation strategies: a review of current literature. BJU Int 112(Suppl 2):21–26

    Article  PubMed  Google Scholar 

  22. Hegarty PK, Eardley I, Heidenreich A et al (2014) Penile cancer: organ-sparing techniques. BJU Int 113(1):133–136

    Article  Google Scholar 

  23. Gulino G, Sasso F, Palermo G et al (2013) Sexual outcomes after organ potency-sparing surgery and glans reconstruction in patients with penile carcinoma. Indian J Urol 29(2):119–123

    Article  PubMed Central  PubMed  Google Scholar 

  24. Garaffa G, Raheem AA, Christopher NA, Ralph DJ (2009) Total phallic reconstruction after penile amputation for carcinoma. BJU Int 104(6):852–856

    Article  PubMed  Google Scholar 

Download references

Einhaltung ethischer Richtlinien

Interessenkonflikt. O.W. Hakenberg und C. Protzel geben an, dass kein Interessenkonflikt besteht. Dieser Beitrag beinhaltet keine Studien an Menschen oder Tieren.

Author information

Authors and Affiliations

  1. Klinik und Poliklinik für Urologie, Universitätsmedizin Rostock, Ernst-Heydemann-Straße 6, 18057, Rostock, Deutschland

    O.W. Hakenberg & C. Protzel

Authors
  1. O.W. Hakenberg
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. C. Protzel
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to O.W. Hakenberg.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Hakenberg, O., Protzel, C. Organerhaltende Therapie beim Peniskarzinom. Urologe 53, 1316–1321 (2014). https://doi.org/10.1007/s00120-014-3525-1

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00120-014-3525-1

Schlüsselwörter

Keywords

Search

Navigation